Lv43
440 积分 2023-08-09 加入
Discovery of T Cell Receptor β Motifs Specific to HLA–B27–Positive Ankylosing Spondylitis by Deep Repertoire Sequence Analysis
15天前
已完结
HLA-B27: what's new?
18天前
已完结
HLA-B27 and spondyloarthritis: at the crossroads of innate and adaptive immunity
18天前
已完结
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci
18天前
已完结
T cell engagers: expanding horizons in oncology and beyond
1个月前
已完结
Shaping secondary pharmacology panels of the future: evolving target selection criteria for safety panels
1个月前
已完结
ILC3 in Axial Spondyloarthritis: the Gut Angle
2个月前
已完结
Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial
2个月前
已完结
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
2个月前
已完结
Secukinumab efficacy in anti-TNF-naive and anti-TNF-experienced subjects with active ankylosing spondylitis: results from the MEASURE 2 Study
2个月前
已完结
皖公网安备34019202002308
